Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Astolfi

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Oncology|November 8, 2005
The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71M C Manara, S Perdichizzi, M Serra, et al.
Journal of Neuroscience Methods|February 1, 2022
TAAC - TMS Adaptable Auditory Control: A universal tool to mask TMS clicksS Russo, S Sarasso, G E Puglisi, et al.
International Journal of Cancer|June 22, 2000
Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cellsC Ricci, L Landuzzi, I Rossi, et al.
British Journal of Cancer|October 2, 2008
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choiceM A Pantaleo, A Astolfi, M Nannini, et al.
The American Journal of Pathology|December 7, 2000
The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kitL Landuzzi, C De Giovanni, G Nicoletti, et al.
Gene Therapy|March 15, 2002
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gammaC De Giovanni, G Nicoletti, L Landuzzi, et al.
Oncogene|February 1, 2011
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signalingC Garofalo, M C Manara, G Nicoletti, et al.
Clinical Sarcoma Research|January 13, 2017
Radiotherapy in the management of gist: state of the art and new potential scenariosL Gatto, M Nannini, M Saponara, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Oncology|November 8, 2005
The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71M C Manara, S Perdichizzi, M Serra, et al.
Journal of Neuroscience Methods|February 1, 2022
TAAC - TMS Adaptable Auditory Control: A universal tool to mask TMS clicksS Russo, S Sarasso, G E Puglisi, et al.
International Journal of Cancer|June 22, 2000
Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cellsC Ricci, L Landuzzi, I Rossi, et al.
British Journal of Cancer|October 2, 2008
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choiceM A Pantaleo, A Astolfi, M Nannini, et al.
The American Journal of Pathology|December 7, 2000
The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kitL Landuzzi, C De Giovanni, G Nicoletti, et al.
Gene Therapy|March 15, 2002
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gammaC De Giovanni, G Nicoletti, L Landuzzi, et al.
Oncogene|February 1, 2011
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signalingC Garofalo, M C Manara, G Nicoletti, et al.
Clinical Sarcoma Research|January 13, 2017
Radiotherapy in the management of gist: state of the art and new potential scenariosL Gatto, M Nannini, M Saponara, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Pageof 4